Increasing endogenous hepatic uridine levels by inhibiting uridine phosphorylase 2 may reduce drug-induced liver lipid accumulation [81, 82], although long-term uridine consumption might promote liver lipid accumulation and exacerbate glucose intolerance [81]. The gene discussed is UPP2; the disease is Glucose intolerance.